Inventor

ZHAO YANGBING

US40 patents

⚠️ This page may combine multiple inventors who share the name “ZHAO YANGBING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZHAO YANGBING

UNIV PENNSYLVANIA

Enhancing activity of CAR T cells by co-introducing a bispecific antibody

Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer

Altering gene expression in modified T cells and uses thereof

Use of ICOS-based CARs to enhance antitumor activity and CAR persistence

Use of gene editing to generate universal TCR re-directed T cells for adoptive immunotherapy

Enhancing activity of CAR T cells by co-introducing a bispecific antibody

Altering gene expression in modified T cells and uses thereof

Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer

Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer

Prostate-specific membrane antigen cars and methods of use thereof

Altering gene expression in cart cells and uses thereof

Methods and compositions for cells expressing a chimeric intracellular signaling molecule

Enhancing activity of CAR T cells by co-introducing a bispecific antibody

Genetically modified immune cells targeting NY-ESO-1 and methods of use thereof

RNA engineered T cells for the treatment of cancer

RNA engineered T cells for the treatment of cancer

Use of ICOS-based CARS to enhance antitumor activity and CAR persistence

Altering gene expression in modified T cells and uses thereof

Altering gene expression in modified T cells and uses thereof

Switch costimulatory receptors

Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer

Modified immune cells having enhanced function and methods for screening the same

Use of gene editing to generate universal TCR re-directed t cells for adoptive immunotherapy

Compositions and methods for gene editing in T cells using CRISPR/Cpf1

Modified immune cells having enhanced function and methods for screening for same

Compositions and methods comprising prostate stem cell antigen (PSCA) chimeric antigen receptors (CARs)

Modified immune cells having enhanced function and methods for screening for same

Compositions and methods for T cell delivery of therapeutic molecules

Use of ICOS-based cars to enhance antitumor activity and car persistence

Prostate-specific membrane antigen cars and methods of use thereof

Compositions and methods of stimulating and expanding T cells

Methods and compositions for cells expressing a chimeric intracellular signaling molecule

UTC THERAPEUTICS SHANGHAI CO LTD

BCMA targetting antibodies, chimeric antigen receptors, and uses thereof

Antigen-binding protein and use thereof

Mesothelin-targetting antibodies, chimeric antigen receptors, and uses thereof

Lymphocytes-antigen presenting cells co-stimulators and uses thereof

NOVARTIS AG

Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules

Enhanced antigen presenting ability of RNA car T cells by co-introduction of costimulatory molecules

JUNE CARL H

Switch costimulatory receptors

THE TRUSTEES OF THE UNIV OF PENNSYLANIA

Compositions and methods for T cell delivery of therapeutic molecules